In this study, we show for the first time that MYLK-AS1 promotes hepatoma cell proliferation, migration and invasion in vitro, and tumor formation in nude mice, through upregulation of EGFR and HER2 as well as their downstream targets (Figure 6C). This evidence concerns the gene EGFR and hepatocellular carcinoma.